Old Well Partners’s LianBio American Depositary Shares LIAN Stock Holding History

Old Well Partners’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-32,200	Closed	-$144K	–	43
2023 Q4	$144K	Hold	32,200	–	–	0.13%	41
2023 Q3	$48K	Hold	32,200	–	–	0.04%	36
2023 Q2	$73.4K	Hold	32,200	–	–	0.07%	31
2023 Q1	$63.1K	Hold	32,200	–	–	0.05%	32
2022 Q4	$52.8K	Hold	32,200	–	–	0.05%	33
2022 Q3	$64K	Hold	32,200	–	–	0.05%	38
2022 Q2	$70K	Buy	32,200 +13,000	+68%	+$44.1K	0.06%	31
2022 Q1	$71K	Buy	19,200 +7,500	+64%	+$31K	0.05%	31
2021 Q4	$72K	Buy	+11,700	New	+$134K	0.04%	40

Other funds holding LIAN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Old Well Partners's LIAN Position: Q1 2024 in Review

Old Well Partners sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 32,200 shares — an estimated $144K sold.

Old Well Partners first reported a position in LIAN in Q4 2021 and held it in 9 quarters. The position peaked at $144K in Q4 2023. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

Old Well Partners reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Old Well Partners sold 32,200 LianBio American Depositary Shares shares in Q1 2024, an estimated $144K.
Old Well Partners first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 9 quarters.
Old Well Partners's LianBio American Depositary Shares position peaked at $144K in Q4 2023.
3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on Old Well Partners's 13F filing for Q1 2024, filed 15 May 2024.